E-cadherin loss drives diffuse-type gastric tumorigenesis via EZH2-mediated reprogramming.
Zou G, Huang Y, Zhang S, Ko KP, Kim B, Zhang J, Venkatesan V, Pizzi MP, Fan Y, Jun S, Niu N, Wang H, Song S, Ajani JA, Park JI.
Zou G, et al. Among authors: huang y.
J Exp Med. 2024 Apr 1;221(4):e20230561. doi: 10.1084/jem.20230561. Epub 2024 Feb 27.
J Exp Med. 2024.
PMID: 38411616